Flanvotumab

DB33656InvestigationalProtein Based Therapies

Flanvotumab: Overview.

Mechanism: Pharmacologically active on 5,6-dihydroxyindole-2-carboxylic acid oxidase
Curator reviewed
Code names: 20-D-7S · IMC-20D7S

Resolves to

Compound

Targets

What you can answer from here — as of August 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Flanvotumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.